Oragenics Receives First European Patent for ProBiora3® Probiotic Blend
[Business Wire] – Oragenics, Inc. today announced it has received its first patent approval in Europe for its ProBiora3® products. The approval provides additional protection for ProBiora3’s proprietary blend of three probiotic bacteria, specifically de more
View todays social media effects on OGEN
View the latest stocks trending across Twitter. Click to view dashboard